JPS5573616A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
JPS5573616A
JPS5573616A JP14272579A JP14272579A JPS5573616A JP S5573616 A JPS5573616 A JP S5573616A JP 14272579 A JP14272579 A JP 14272579A JP 14272579 A JP14272579 A JP 14272579A JP S5573616 A JPS5573616 A JP S5573616A
Authority
JP
Japan
Prior art keywords
antitumor agent
antitumor
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14272579A
Other languages
English (en)
Japanese (ja)
Inventor
Nasu Seegaru Sarendora
Bechina Kuraudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Publication of JPS5573616A publication Critical patent/JPS5573616A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP14272579A 1978-11-03 1979-11-02 Antitumor agent Pending JPS5573616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95762678A 1978-11-03 1978-11-03

Publications (1)

Publication Number Publication Date
JPS5573616A true JPS5573616A (en) 1980-06-03

Family

ID=25499878

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14272579A Pending JPS5573616A (en) 1978-11-03 1979-11-02 Antitumor agent

Country Status (3)

Country Link
JP (1) JPS5573616A (fr)
BE (1) BE877700A (fr)
ZA (1) ZA795449B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159716A (en) * 1981-03-09 1982-10-01 Ayerst Mckenna & Harrison Antitumoral agent
JP2004525950A (ja) * 2001-04-06 2004-08-26 ワイス ラパマイシンとゲムシタビンまたはフルオロウラシルなどの、抗腫瘍剤の組み合わせ
JP2006524246A (ja) * 2003-04-22 2006-10-26 ワイス 抗新生物組み合わせ
WO2009110415A1 (fr) * 2008-03-03 2009-09-11 武田薬品工業株式会社 Médicament concomitant
JP2010018620A (ja) * 2000-11-15 2010-01-28 Wyeth Llc 抗腫瘍剤としてのｃｃｉ−７７９の使用
JP2012184238A (ja) * 2001-02-19 2012-09-27 Novartis Ag 癌の処置
JP2020537695A (ja) * 2017-10-24 2020-12-24 エムディー バイオラボ カンパニー リミテッドＭｄ Ｂｉｏｌａｂ Ｃｏ．， Ｌｔｄ． ストレプトニグリンおよびラパマイシンを有効成分として含む、癌の予防または治療用薬学的組成物

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU543727B2 (en) 1980-06-02 1985-05-02 Ayerst Mckenna & Harrison Inc. Injectable composition of rapamycin
US4316885A (en) 1980-08-25 1982-02-23 Ayerst, Mckenna And Harrison, Inc. Acyl derivatives of rapamycin
US4650803A (en) * 1985-12-06 1987-03-17 University Of Kansas Prodrugs of rapamycin
DE69209183T2 (de) * 1991-06-18 1996-08-08 American Home Prod Verwendung von Rapamycin zur Behandlung von T-Zellen Lymphom/Leukämie bei Erwachsenen
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57159716A (en) * 1981-03-09 1982-10-01 Ayerst Mckenna & Harrison Antitumoral agent
JP2010018620A (ja) * 2000-11-15 2010-01-28 Wyeth Llc 抗腫瘍剤としてのｃｃｉ−７７９の使用
JP2012184238A (ja) * 2001-02-19 2012-09-27 Novartis Ag 癌の処置
JP2015145411A (ja) * 2001-02-19 2015-08-13 ノバルティス アーゲー 癌の処置
JP2004525950A (ja) * 2001-04-06 2004-08-26 ワイス ラパマイシンとゲムシタビンまたはフルオロウラシルなどの、抗腫瘍剤の組み合わせ
JP2006524246A (ja) * 2003-04-22 2006-10-26 ワイス 抗新生物組み合わせ
WO2009110415A1 (fr) * 2008-03-03 2009-09-11 武田薬品工業株式会社 Médicament concomitant
JP2020537695A (ja) * 2017-10-24 2020-12-24 エムディー バイオラボ カンパニー リミテッドＭｄ Ｂｉｏｌａｂ Ｃｏ．， Ｌｔｄ． ストレプトニグリンおよびラパマイシンを有効成分として含む、癌の予防または治療用薬学的組成物

Also Published As

Publication number Publication date
ZA795449B (en) 1980-11-26
BE877700A (fr) 1980-01-14

Similar Documents

Publication Publication Date Title
GB2026516B (en) Chitinglucan complexes
GB2025195B (en) Combined mowerconditioner
GB2021097B (en) Antiviral agent
PT69349A (en) Chemotherapeutic agent
GB2023131B (en) Anti-tumour agent ks-2-b
JPS5573616A (en) Antitumor agent
JPS52145509A (en) Antitumor agent
JPS55164624A (en) Antitumor
JPS54130516A (en) Acyllnnacetylmuramylpeptide derivativeeantigen combination
JPS5391109A (en) Antitumor agent
JPS5587706A (en) Egggkilling agent
JPS54129111A (en) Krebshemmende agent
JPS56123913A (en) Antitumor
JPS54138115A (en) Antiicancer agent
JPS54147932A (en) Antiicancer agent
JPS5344614A (en) Antitumor agent
JPS565477A (en) Pyridylaminotriazole antitumor
ZA794011B (en) Dietetic agent
JPS5534223A (en) Polypyrrolidoneeiodine complex
JPS5334914A (en) Antitumor agent
CS771179A2 (en) Zpusob vyroby selektivne acylovaneho n chraneneho derivatu aminoglykosidoveho antibiotika
JPS54140711A (en) Antiicancer agent
JPS54117017A (en) Antiitumor agent
JPS54157839A (en) Antiicancer agent
JPS5436293A (en) Antiibacterial agent